Loading viewer...
earnings
Format: PDF earnings
Teva Pharmaceutical Industries reported second quarter 2021 financial results on July 28, 2021. The presentation includes forward-looking statements regarding competitive pressures in generics and specialty pharmaceuticals, debt management, and business optimization efforts. Key product lines discussed include AUSTEDO, AJOVY, and COPAXONE amid regulatory and market challenges.
investor_presentation
37 Pages
earnings
41 Pages
Adani Group
The Trade Desk Q4 FY2018 Investor Presentation
earningsearnings
39 Pages
The Trade Desk, Inc.
Wheels Up Q1 2023 Earnings Presentation
earningsearnings
15 Pages
Wheels Up Experience Inc.